Suchergebnisse
EQS-News: BVB Japan-Tour 2026: Rekordreichweiten, 70.000 Fankontakte und starke kommerzielle Impulse
CGTN: Warum China zu einem beliebten Sommerreiseziel geworden ist
PEKING, July 28, 2026 (GLOBE NEWSWIRE) -- CGTN hat einen Artikel veröffentlicht, der sich mit dem Reiseboom in China befasst. Da immer mehr Reisende aus aller Welt auf der Suche nach kühleren
CGTN: Warum China zu einem beliebten Sommerreiseziel geworden ist
PEKING, July 28, 2026 (GLOBE NEWSWIRE) -- CGTN hat einen Artikel veröffentlicht, der sich mit dem Reiseboom in China befasst. Da immer mehr Reisende aus aller Welt auf der Suche nach kühleren
Fulgent Genetics Q2 Earnings Call Highlights
Key Points
- Interested in Fulgent Genetics, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose to $85.4 million, up 20% sequentially, with Bako Diagnostics and StrataDx
Fidus Investment Q2 Earnings Call Highlights
Key Points
- Interested in Fidus Investment Corporation? Here are five stocks we like better.
- Adjusted net investment income was $0.50 per share, covering Fidus Investment’s base dividend. The
Betterware de Mexico SAPI de C Q2 Earnings Call Highlights
Key Points
- Interested in Betterware de Mexico SAPI de C? Here are five stocks we like better.
- Betterware posted stronger Q2 results as core brands returned to growth and the newly acquired
IBM Aktie: 24. Juli im Fokus
Kaum hat sich der Kurs von seinem historischen Absturz erholt, prüfen mehrere US-Kanzleien bereits…
Der Beitrag IBM Aktie: 24. Juli im Fokus erschien zuerst auf kapitalmarktexperten.de.
Quelle kapit
EQS-News: BVB Japan Tour 2026: Record Reach, 70,000 Fan Contacts and Strong Commercial Momentum
Can NVIDIA's Sovereign AI Push Unlock New Revenue Streams Now?
NVIDIA Corporation NVDA is expanding beyond traditional cloud customers by targeting sovereign artificial intelligence (AI) projects, a fast-growing market where governments build domestic AI
Wall Street Analysts Believe Darling (DAR) Could Rally 32.41%: Here's is How to Trade
Shares of Darling Ingredients (DAR) have gained 3.6% over the past four weeks to close the last trading session at $58.62, but there could still be a solid upside left in the stock if short-term
Buyback Boom: These 3 Companies Are Betting Billions on Their Own Stocks
Key Points
- Interested in Dollar Tree, Inc.? Here are five stocks we like better.
- Dollar Tree, Morgan Stanley, and Accenture recently announced a combined $24.5 billion in new, replenished, or
VLO Q2 Earnings Call Highlights Refining Strength
Valero Energy Corporation VLO emphasized strong operating execution and a supportive market backdrop during its second-quarter 2026 earnings call, with management focusing on refining margins, fuel
Carlyle Secured Lending Q2 Earnings Call Highlights
Key Points
- Interested in Carlyle Secured Lending, Inc.? Here are five stocks we like better.
- Net investment income of $24 million, or $0.35 per share, fully covered the revised base dividend
SGI Stock Tracks Bedding Trends in Retail Costs and Global Growth
Somnigroup International Inc. SGI is being judged on two connected themes: whether bedding demand improves and whether retail costs stay manageable. The company has a bigger platform after the
SpaceX Stock Has Plunged: Buy it Now?
- (0:20) - Is Now A Good Time To Invest Into SpaceX?
- (3:00) - Breaking Down SpaceX and Tesla’s Current Valuations
- (22:15) - Episode Roundup: SPCX, TSLA
- [email protected]
Welcome
IBM Aktie: 37-Prozent-Einbruch seit Juni-Hoch
IBM sitzt in einer paradoxen Klemme. Der KI-Boom, den die ganze Tech-Branche feiert, frisst…
Der Beitrag IBM Aktie: 37-Prozent-Einbruch seit Juni-Hoch erschien zuerst auf kapitalmarktexperten.de.
Qu
Bausch Health Cos Q2 Earnings Call Highlights
Key Points
- Interested in Bausch Health Cos Inc.? Here are five stocks we like better.
- Bausch Health raised its full-year outlook after reporting strong second-quarter growth: excluding Bausch +
Is SAM Stock Worth Buying After Earnings Misses and Estimate Cuts?
The Boston Beer Company, Inc. SAM has financial strengths that should not be dismissed. It has no debt, solid cash generation and improving gross margins.
The problem is that weak demand is cutting
argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102
Key Points
- Interested in argenex SE? Here are five stocks we like better.
- argenx agreed to acquire Forte Biosciences for approximately $2.2 billion in equity value, offering $77 per share in